Literature DB >> 29297778

Chronic cholestasis is associated with hypogonadism and premature ovarian failure in adult rats (cholestasis causes ovarian hypogonadism).

Yomna I Mahmoud1.   

Abstract

Hypogonadism is a well-known complication in males with chronic liver diseases. However, the consequences of chronic hepatopathies on female reproductive capacities have received relatively little attention. The present study evaluates the effect of chronic obstructive jaundice on the ovary of adult cycling rats. Estrous cyclicity was monitored to check the functional status of the hypothalamic-pituitary-ovarian axis. Ovarian changes were assessed using histomorphometric, immunohistochemical, and ultrastructural techniques. Chronic cholestasis was associated with estrous cycle irregularities, diminished ovarian weight, primordial follicle loss, atretic follicle prevalence, marked stromal fibrosis, and diminished immunoexpression of proliferation marker and estrogen receptors, in addition to many ultrastructural alterations in theca, granulosa cells, and oocytes of antral follicles. The results establish that chronic cholestasis causes hypogonadism and premature ovarian insufficiency in adult cycling female rats.

Entities:  

Keywords:  Cholestasis; hypogonadism; ovarian reserve; rat; ultrastructure

Mesh:

Year:  2018        PMID: 29297778     DOI: 10.1080/01913123.2017.1415401

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  2 in total

1.  A Network Pharmacology Approach to Uncover the Potential Mechanism of Yinchensini Decoction.

Authors:  Guoming Chen; Chuyao Huang; Yunyun Liu; Tengyu Chen; Ruilan Huang; Miaozhen Liang; Jie Zhang; Hua Xu
Journal:  Evid Based Complement Alternat Med       Date:  2018-12-20       Impact factor: 2.629

Review 2.  Effectiveness of Cotreatment with Kuntai Capsule and Climen for Premature Ovarian Failure: A Meta-Analysis.

Authors:  Qianwen Ma; Yong Tan; Genlin Mo
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-19       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.